المؤلفون: Dilly J; Dana-Farber Cancer Institute, Boston, MA, United States., Hoffman MT; Dana-Farber Cancer Institute, Boston, MA, United States., Abbassi L; Dana-Farber Cancer Institute, Boston, MA, United States., Li Z; Dana-Farber Cancer Institute, Boston, MA, United States., Paradiso F; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Parent BD; Dana-Farber Cancer Institute, Boston, MA, United States., Hennessey CJ; Dana-Farber Cancer Institute, Boston, MA, United States., Jordan AC; Dana-Farber Cancer Institute, Boston, MA, United States., Morgado M; Dana-Farber Cancer Institute, Boston, MA, United States., Dasgupta S; Broad Institute, Cambridge, MA, United States., Uribe GA; Dana-Farber Cancer Institute, Boston, MA, United States., Yang A; Dana-Farber Cancer Institute, Boston, MA, United States., Kapner KS; Dana-Farber/Harvard Cancer Center, Boston, United States., Hambitzer FP; Dana-Farber Cancer Institute, Boston, MA, United States., Qiang L; Dana-Farber Cancer Institute, Boston, United States., Feng H; Dana-Farber Cancer Institute, Boston, United States., Geisberg J; Dana-Farber Cancer Institute, Boston, MA, United States., Wang J; Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, United States., Evans KE; Dana-Farber Cancer Institute, Boston, MA, United States., Lyu H; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Schalck A; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Feng N; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Lopez AM; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Bristow CA; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Kim MP; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Rajapakshe KI; The University of Texas MD Anderson Cancer Center, United States., Bahrambeigi V; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Roth JA; Broad Institute, Cambridge, MA, United States., Garg K; Resolution Bioscience, United States., Guerrero PA; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Stanger BZ; University of Pennsylvania, Philadelphia, Pennsylvania, United States., Cristea S; Dana-Farber Cancer Institute, Boston, United States., Lowe SW; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Baslan T; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Van Allen EM; Dana-Farber Cancer Institute, Boston, MA, United States., Mancias JD; Dana-Farber Cancer Institute, Boston, MA, United States., Chan E; Amgen (United States), Thousand Oaks, CA, United States., Anderson A; Amgen Inc., Thousand Oaks, CA, United States., Katlinskaya YV; Amgen Inc., Thousand Oaks, CA, United States., Shalek AK; Massachusetts Institute of Technology, Cambridge, MA, United States., Hong DS; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Pant S; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hallin J; Mirati Therapeutics (United States), San Diego, CA, United States., Anderes K; Mirati Therapeutics (United States), San Diego, CA, United States., Olson P; Mirati Therapeutics (United States), San Diego, CA, United States., Heffernan TP; The University of Texas MD Anderson Cancer Center, Houston, United States., Chugh S; Dana-Farber Cancer Institute, Boston, MA, United States., Christensen JG; Mirati Therapeutics (United States), San Diego, CA, United States., Maitra A; The University of Texas MD Anderson Cancer Center, United States., Wolpin BM; Dana-Farber/Harvard Cancer Center, Boston, MA, United States., Raghavan S; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Nowak JA; Brigham and Women's Hospital, Boston, MA, United States., Winter PS; Massachusetts Institute of Technology, Cambridge, MA, United States., Dougan SK; Dana-Farber Cancer Institute, Boston, MA, United States., Aguirre AJ; Dana-Farber Cancer Institute, Boston, MA, United States.

المصدر: Cancer discovery [Cancer Discov] 2024 Jul 08. Date of Electronic Publication: 2024 Jul 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE